Product correctly added to cart.

discount label
Pergolide sulfone
View 3D

Biosynth logo

Pergolide sulfone

CAS: 72822-03-8

Ref. 3D-FP26841

1mgTo inquire
2mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Tuesday 2 Jul 2024

Product Information

Name:
Pergolide sulfone
Synonyms:
  • (8b)-8-[(Methylsulfonyl)methyl]-6-propyl-ergoline
Description:

Pergolide sulfone is a prodrug that is converted to its active form, pergolide mesylate, in vivo. Pergolide sulfone has been shown to be active against Parkinson's disease and other disorders of the central nervous system. It has been used for the treatment of Parkinson's disease since 1984. In clinical studies, pergolide sulfone was found to be effective in reducing the symptoms of Parkinson's disease. The most common side effects are nausea and vomiting, which occur in up to 10% of people who take it. Pergolide sulfone binds to dopamine D2 receptors in the striatum and may cause an increase in plasma concentrations of acetylcholine and dopamine by blocking their reuptake into nerve terminals; this leads to increased neurotransmission. The major metabolite formed from pergolide sulfone is a sulfoxide that can be detected by chromatography.br>br>
Pergolide mesylate is

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
346.49 g/mol
Formula:
C19H26N2O2S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FP26841 Pergolide sulfone

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".